Back to today’s briefing

Story perspectives

Trump's Executive Order Targets Soaring Medication Prices Amid Health Crisis

6/17/2025

46 5

Summary

Story summary

In May 2025, President Trump took a bold step by signing an executive order aimed at slashing the soaring prices of medications. As 36% of US employers embraced coverage for GLP-1 drugs to combat diabetes and aid weight management, a looming FDA ban on compounded versions threatens to restrict access. Meanwhile, a J.D. Power study unveiled growing dissatisfaction among health insurance plan members, highlighting a pressing need for reform.

1 of 1

Story summary

In May 2025, President Trump took a bold step by signing an executive order aimed at slashing the soaring prices of medications. As 36% of US employers embraced coverage for GLP-1 drugs to combat diabetes and aid weight management, a looming FDA ban on compounded versions threatens to restrict access. Meanwhile, a J.D. Power study unveiled growing dissatisfaction among health insurance plan members, highlighting a pressing need for reform.